SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-16-027775
Filing Date
2016-11-07
Accepted
2016-11-04 21:42:00
Documents
69
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q orex-10q_20160930.htm 10-Q 1983909
2 EX-31.1 orex-ex311_11.htm EX-31.1 8111
3 EX-31.2 orex-ex312_10.htm EX-31.2 8434
4 EX-32.1 orex-ex321_9.htm EX-32.1 4580
5 EX-32.2 orex-ex322_8.htm EX-32.2 4719
  Complete submission text file 0001564590-16-027775.txt   7601054

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT orex-20160930.xml EX-101.INS 1692624
7 XBRL TAXONOMY EXTENSION SCHEMA orex-20160930.xsd EX-101.SCH 50530
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE orex-20160930_cal.xml EX-101.CAL 68585
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE orex-20160930_def.xml EX-101.DEF 206078
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE orex-20160930_lab.xml EX-101.LAB 407345
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE orex-20160930_pre.xml EX-101.PRE 327955
Mailing Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037
Business Address 3344 N. TORREY PINES CT. SUITE 200 LA JOLLA CA 92037 (858) 875-8600
Orexigen Therapeutics, Inc. (Filer) CIK: 0001382911 (see all company filings)

IRS No.: 651178822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33415 | Film No.: 161976392
SIC: 2834 Pharmaceutical Preparations